5 results
diagnosis hematology syndrome algorithm anthracycline anticoagulation apml cancer cardiotoxicity chemotherapy differentiation her2 malignancy pericarditis recurrent sjogrens vte
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... anticoagulants (DOACs ... thrombosis; PE = pulmonary ... Anticoagulation #Management ... #Hematology #Oncology
►
 Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... Renal Failure Treatment ... APML #diagnosis #management ... #hematology #oncology
Acute Recurrent Pericarditis = recurrence of Acute Pericarditis (AP) after free interval >4-6 weeks without symptoms, >1/4
RED FLAGS: Fever ... Systemic symptoms: pulmonary ... Pericarditis #diagnosis #management ... #treatment #rheumatology ... #cardiology
Sjogren's Syndrome Overview Epidemiology: • F > M: 9:1 • 5-6th Decades (can be any age) Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Sjogrens #Syndrome #Rheumatology ... #Diagnosis #Management
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity Anthracyclines cause cardiomyopathy: ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... ) and initiate treatment ... Cardiotoxicity #cardiology ... #oncology #pharmacology ... #toxicity #chemotherapy
No results found for "Lever treatment management pulmonary rheumatology pharmacology oncology doac toxicity cardiology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Lever #treatment #management #pulmonary #rheumatology #pharmacology #oncology #doac #toxicity #cardiology